Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

Usman Baber,Shawn X. Li,Rebecca Pinnelas,Stuart J. Pocock,Mitchell W. Krucoff,Cono Ariti,C. Michael Gibson,Philippe Gabriel Steg,Giora Weisz,Bernhard Witzenbichler,Timothy D. Henry,Annapoorna Kini,Thomas D. Stuckey,David J. Cohen,Ioannis Iakovou,George Dangas,Melissa Aquino,Samantha Sartori,Alaide Chieffo,David J. Moliterno,Antonio Colombo,Roxana Mehran

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

2018

Background—Patients with chronic kidney disease(CKD) experience high rates of ischemic and bleeding events after percutaneous coronary intervention(PCI), complicating decisions surrounding dual a...

Keywords:

Percutaneous coronary intervention
Internal medicine
Kidney disease
Cardiology
Conventional PCI
Medicine

Correction
Cite
Save

References

Citations